Anna Ejduk

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study

Hagop M. Kantarjian, Daniel J. DeAngelo, Anjali S. Advani et al. · The Lancet Haematology · 2017 · 212 citations

Medicine, Hematology, Pharmacology +17

Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland

Piotr Grabarczyk, Aleksandra Kalińska, Mahmut Zabit Kara et al. · Journal of Medical Virology · 2010 · 36 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of high‐resolution melting analysis with direct sequencing for the detection of recurrent mutations in <scp>DNA</scp> methyltransferase 3<scp>A</scp> and isocitrate dehydrogenase 1 and 2 genes in acute myeloid leukemia patients

Patryk Górniak, Anna Ejduk, Katarzyna Borg et al. · European Journal Of Haematology · 2015 · 20 citations

Life Sciences, Genetics, Molecular Biology +13

The relevance of HPA‐15 antigen expression for anti‐HPA‐15 antibody detection

Krystyna Maślanka, Halina Michur, Katarzyna Guz et al. · International Journal of Laboratory Hematology · 2011 · 14 citations

Medicine, Hematology, Immunology +15

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study

Bożena Katarzyna Budziszewska, Agnieszka Pluta, Agnieszka Wierzbowska et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 13 citations

Medicine, Geriatric Medicine, Oncology +17